Effects of CO2 Gas Properties on Post-Operative Pain


PATIENTS & METHODS
Fifty (50) morbidly obese patients underwent laparoscopic Rouxen-Y gastric bypass. Control group (cold dry gas, n=21) and Insuflow®; humidifying gas conditioning group (n=23) in a randomized prospective controlled study.
RESULTS
Use of the Insuflow®; device had 1) statistically significant higher intraoperative core body temperature, 2) no post-operative shivering, 3) less post-operative morphine analgesia, and 4) a higher quality of recovery by post-operative day two.
CONCLUSION
Pre-conditioning laparoscopic gas by filtering heating and hydrating with the Insuflow®; device was significantly more effective than the currently used standard raw gas and was safe in reducing or eliminating laparoscopic induced hypothermia, shortening recovery room length of stay and reducing post-operative pain.
This is a piglet study about abdominal insufflation comparing two groups of five using either traditional cold dry or warm, humidified carbon dioxide (CO2).
RESULTS
Radiographic gas bubble profile calculation and blood sample testing of IL-1 and TNF up to 5 hours. Residual CO2 dissipates more rapidly when the gas is heated and humidified compared with cold and dry gas. The humidified warm gas group had “a reduction in the duration of inflammatory response as measured by TNF production.”
CONCLUSION
“Heating and humidifying CO2 leads to faster dissipation of residual gas associated with a reduced duration of inflammation, which may contribute toward a reduction in post-laparoscopic pain. ”
ABSTRACT
The Insuflow®; device was associated with significantly higher core body temperature after one hour of insufflation. Pain scores and opioid analgesic requirements were significantly lower in the Insuflow®; group. The length of stay in the PACU and hospital were shorter in the Insuflow®; group but not significantly different. The patients in the Insuflow®; group reported a better quality of recovery on post-operative day #2.
METHODS
A double blind, prospective, randomized study comparing patients undergoing laparoscopic cholecystectomy with cold, dry CO2 insufflation versus warmed, humidified CO2 (Insuflow®;, LEXION Medical, St. Paul, MN) was performed. Main variables included patient temperature, lens fogging, post-operative pain, and narcotic requirements.
RESULTS
101 blinded patients (69 women, 32 men) undergoing laparoscopic cholecystectomy were randomized into two groups: 52 having standard CO2 insufflation (Group A) and 49 given warmed, humidified CO2 (Group B). Statistical differences between groups were seen with mean patient intraoperative temperature change (Group A decreased by 0.03ºC, Group B increased by 0.29ºC, p=0.01) and mean abdominal pain decreased (Likert scale 0-10) at 14 days (A=1.0, B=0.3, p=0.02).
COMMENT
The statistically significant findings were 4-fold: patients were warmer intraoperatively using the Insuflow®; device, they harbored less shoulder pain at PACU entry, they had less abdominal pain at 2 weeks post-operatively, and they used less pain medication at 2 weeks post-operatively.
CONCLUSION
Patients who received warm and humidified carbon dioxide (Insuflow®; device) during laparoscopic roux-en-y gastric bypass surgery for morbid obesity required significantly less post-operative analgesia than those who did not.
ABSTRACT
Complications of laparoscopy are categorized into trocar insertion complications, complications resulting from image quality, and complications resulting from instrumentation. The cause of shoulder pain is focused on the drying effect of the carbon dioxide on the peritoneal cell. The low humidity results in mesothelial integrity being lost, and the basal lamina exposed. Heating and humidifying the carbon dioxide with the Insuflow®; device to 37ºC and 95% relative humidity prior to insufflation into the peritoneal cavity maintains body temperature even during prolonged laparoscopic procedures. There is also a decrease in shoulder pain and its frequency and a decrease in post-operative pain and shortened length of stay compared to dry gas.
ABSTRACT
Insuflow®; was used in 10 laparoscopic kidney donors during a 2-month period. The data was compared with 10 contemporaneous donors without Insuflow®; use. Length of hospital stay (3.3 vs. 3.8 days) and post-operative analgesic use measured in morphine equivalents (62 mg vs. 69 mg) were no different between groups. However, Insuflow®; patients spent less time in the recovery room (94 vs. 140 minutes) (p=0.02), had decreased incidence of shoulder pain (0% vs. 40%) (p=0.09) and shivering (0% vs. 40%) (p=0.09). At the end of the procedure 70% of the non-Insuflow®; patients were hypothermic compared to none in the Insuflow®; group. The Insuflow®; device decreases the incidence of hypothermia and shivering and may be associated with decreased peritoneal desiccation leading to decreased incidence of shoulder tip pain.
No adverse effects from humidification of insufflated gas. Pain significantly reduced at 6 hours, first, second and third days. In the humidified group the mean time taken to return to normal activities was significantly less; 5.9 days compared to 10.9 days in the control group – a 54% improvement.
CONCLUSION
The use of humidified insufflation gas reduces post-operative pain following laparoscopic cholecystectomy.
CONCLUSION
The Insuflow®; device may be a useful alternative to forced air warming devices during major laparoscopic surgery. Although less effective in maintaining core temperature than the external forced air warming device, the Insuflow®; improved pain control and reduced the need for opioid analgesics and antiemedics in the post-operative period.
Awake Microlaparoscopy with the Insuflow®; Device
RESULTS
The incidence of transient shoulder pain in the Insuflow®; group was 5% compared with 40% in the dry carbon dioxide group. No patient in the Insuflow®; group complained of shivering, whereas 55% in the control group had shivering. Fogging of the microlaparoscope lens was decreased in the Insuflow®; group.
CONCLUSION
Heating and humidifying the carbon dioxide gas produced fewer patient complaints of shoulder pain and shivering and decreased fogging of the microlaparoscope lens compared with procedures done with dry carbon dioxide during awake microlaparoscopic procedures.
Hypothermia is created by the gas reducing the well being of the patient and increasing post-operative analgesia.
RESULTS
Patients exposed to CO2 gas modified by the Insuflow®; device had absent or dramatically reduced shoulder pain. This allowed a significant increase in surgical time to perform diagnosis and treatment due to increased patient comfort. Those women who had shoulder pain, it was transitory, less intense, and of shorter duration than in those exposed to the currently used cold, dry CO2. Post-operative recovery time was shortened in the Insuflow®; device group with 80% of patients leaving the hospital within 90 minutes.
CONCLUSION
Heating and humidifying CO2 increases patient tolerance during awake laparoscopy using local anesthesia, decreases the frequency and duration of shoulder pain, shortens recovery time and improves safety of the procedure.
Background Post-operative laparoscopic pain is a problem with as many as 80% of patients requiring opioid analgesia.
CONCLUSION
To reduce pain, use humidified gas at body temperature.
BACKGROUND
Insufflation with standard cold-dry CO2 during laparoscopic surgery has been shown to predispose patients to hypothermia and peritoneal injury. This study aimed to compare the effect of prolonged cold-dry CO2 insufflation with heated-humidified CO2 insufflation (3-5 h) on hypothermia, peritoneal damage, and intra-abdominal adhesion formation in a rat model.
MATERIALS AND METHODS
A total of 160 Wistar rats were randomized to undergo no insufflation or insufflation with cold-dry CO2 (21°C, <1% relative humidity) or heated-humidified CO2 (37°C, 95% relative humidity) for 3, 4, or 5 h. Core body temperature was measured via rectum before and during insufflations. Peritoneal samples were taken at 6, 24, 48 and 96 h after treatments and analyzed with light microscopy and scanning electron microscopy. Intra-abdominal adhesions were evaluated 2 weeks later.
RESULTS
Core body temperature significantly decreased in the cold-dry group, wheras it was maintained and increased in the heated-humidified group. Scanning electron microscopy and light microscopy studies showed intense peritoneal injury in the cold-dry CO2 group but significantly less damages in the heated-humidified group. Increased intra-abdominal adhesion formation was observed in the cold-dry CO2 group, while no adhesions were found in the rats insufflated with heated-humidified CO2.
CONCLUSIONS
Heated-humidified CO2 insufflation results in significantly less hypothermia, less peritoneal damage, and decreased adhesion formation as compared with cold-dry CO2 insufflation. Heated-humidified CO2 may be more suitable for insufflation applications in prolonged laparoscopic surgery.
OBJECTIVE
To study whether using 95% humidified, heated carbon dioxide (CO2) at laparoscopy reduces pain compared with dry, heated CO2.
METHODS
Patients were randomly assigned to either heated, 95% humidified CO2 (study group) or heated, dry CO2 (control group) during laparoscopy. Pain control was achieved per standard protocols. Pain scales were administered the first 4 hours and 24 and 48 hours postoperatively.
RESULTS
The 89 patients available in the intent-to-treat model revealed a decrease in total morphone equivalents and a decrease in pain scores at 1, 2, and 24 hours in the study group. (directional P values < .05). Subgroup analysis in patients without chronic pelvic pain revealed lower mean pain scores at 1, 2, 24, and 48 hours and decreases in postoperative and total morphine equivalents (directional P values < .05) in the study group.
CONCLUSION
At laparoscopy, heated, 95% humidified CO2 effectively decreases postoperative pain and narcotics usage compared with heated, dry CO2.